Acute and Chronic Leukemias Flashcards
Myelogenous Leukemias
Acute Myelogenous Leukemia (AML)
Gazillion subtypes
Chronic Myelogenous Leukemia (CML
Lymphocytic/ Lymphoblastic Leukemias
Acute Lymphoblasic Leukemia (ALL)
B cell
T cell
Chronic Lymphocytic Leukemia (CLL)
Hairy Cell Leukemia
Adult T cell Leukemia
HTLV-1
Leukemias by age
0- adolescent (0-14): ALL Adolescent to adult (15-59): AML Adult(40-60+): AML/CML Elderly adult (>60): CLL
Acute Myelogenous Leukemia
Young to middle aged adults
Maturational arrest in granulocyte development, leading to proliferation of malignant precursor cells
Clinical features of AML
EVIDENCE OF MARROW FAILURE Anemia Thrombocytopenia Neutropenia Leukocytosis with ↑↑ blasts diffuse bone marrow infiltration
Auer rods can be present
Signs and symptoms of AML
Fatigue
Bleeding/ecchymoses
DIC (APL)
Gum infiltration (monocytic)
Acute Promyelocytic Leukemia
Corresponds to FAB M3 WHO APML with t(15;17)(q22;q12)- TRANSLOCATION 15:17 5-8% of AML Any age, but usually 3-5 decades of life Frequently presents with DIC Rapid doubling time Often has large numbers of Auer rods
Acute Promyelocytic Leukemia treatment and prognosis
Treat with ATRA and alkylating agent
80-90% remission
Acute Monocytic Leukemia
Auer rods are rare
GUM INFILTRATION is frequently the presenting sign
Diagnosis hinges on immunophenotype (CD markers)
Chronic Myelogenous Leukemia
15% of adult leukemias
May be related to radiation or benzene
Pluripotent
t(9;22) BCR-ABL fusion gene … aka Philadelphia chromosome
Protracted chronic phase, sometimes many years, followed by BLAST CRISIS
Philadelphia Chromosome
De novo mutation
NOT specific for CML
BCR-ABL1 fusion gene produces a constitutively ACTIVE TYROSINE KINASE, leading to dysregulation of proliferation and normal apoptosis
Chronic Myelogenous Leukemia Clinical Features
WBC >5x109/L Characteristic diff, with FULL SPECTRUM OF GRANULOCYTES REPRESENTED <10% BLASTS Fever, night sweats, weight loss Splenomegaly Bleeding/ecchymoses
What is blast crisis
Progression to acute leukemia
> 20% blasts
Large aggregates in BM and extramedullary tissue
Usually fatal
CML treatment and prognosis
The prognosis depends on response to TKI’s (e.g. imatinib; aka Gleevec)
With allogenic stem cell transplant, 5-year progression-free survival 80-95%
B Cell Acute Lymphoblastic Leukemia
Most common leukemia in children 80-85% of ALL are B-cell 75% of cases involve children under 6 yo Primitive, undifferentiated lymphoblasts Express CD10, tdt (flow cytometry)